Trial site
Chiba
- 18running trials
- 10closed trials
The trials here
What the 28 trials at this site are about, from their registry records.
- Conditions
- Childhood cancers4 trials
- IgA nephropathy4 trials
- Prostate cancer4 trials
- Multiple sclerosis3 trials
- Myasthenia gravis3 trials
- Chronic myeloid leukaemia2 trials
- Acute lymphoblastic leukaemia1 trial
- ANCA-associated vasculitis1 trial
- Aplastic anaemia1 trial
- Chronic kidney disease1 trial
- Diffuse large B-cell lymphoma1 trial
- Familial hypercholesterolaemia1 trial
- and 5 more
- Phase
- Phase 313 trials
- Phase 25 trials
- Phase 1/21 trial
- Phase 2/31 trial
- Status
- Active, not recruiting13 trials
- Completed9 trials
- Recruiting5 trials
- Withdrawn1 trial
- Lead sponsor
- Novartis Pharmaceuticals28 trials
Running trials
Recruiting
Recruiting
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Active, not recruiting
Study to Assess Safety, Efficacy, and Cellular Kinetics of YTB323 in Generalized Myasthenia Gravis
Active, not recruiting
Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA or MPA
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Prostate cancer2 recruiting
- Acute lymphoblastic leukaemia1 recruiting
- Aplastic anaemia1 recruiting
- Childhood cancers1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- IgA nephropathy1 recruiting
Closed trials
Completed
Recruiting
Completed
Completed
Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer in Japan
Completed
Completed
Special Drug-use Surveillance for Kesimpta for s.c. Injection 20 mg Pen
Completed
Study of Efficacy and Safety of Canakinumab in Japanese Patients With AOSD
Completed
Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients
Completed
Completed
Treatment-free Remission After Achieving Sustained MR4.5 on Nilotinib (ENESTop)
Site data: ClinicalTrials.govUpdated 17 Nov 2026